In vivo evaluation of cetuximab-conjugated poly(γ-glutamic acid)-docetaxel nanomedicines in EGFR-overexpressing gastric cancer xenografts

References

• PowerDGKelsenDPShahMAAdvanced gastric cancer–Slow but steady progressCancer Treat Rev201036538439220176443
   PubMed Web of Science ®Google Scholar
• WagnerADUnverzagtSGrotheWChemotherapy for advanced gastric cancerCochrane Database Syst Rev201033CD004064
   Google Scholar
• SiegelRLMillerKDJemalACancer statistics, 2016CA Cancer J Clin201666173026742998
   PubMed Web of Science ®Google Scholar
• FuseNKubokiYKuwataTPrognostic impact of HER2, EGFR, and c-MET status on overall survival of advanced gastric cancer patientsGastric Cancer201619118319125682441
   PubMedGoogle Scholar
• SakaiKMoriSKawamotoTExpression of epidermal growth factor receptors on normal human gastric epithelia and gastric carcinomasJ Natl Cancer Inst1986775104710523464796
   PubMed Web of Science ®Google Scholar
• TakehanaTKunitomoKSuzukiSExpression of epidermal growth factor receptor in gastric carcinomasClin Gastroenterol Hepatol20031643844515017643
   PubMedGoogle Scholar
• PintoCDi FabioFSienaSPhase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)Ann Oncol200718351051717164226
   PubMed Web of Science ®Google Scholar
• ZhangYCaoYLuoSMukerabigwiJFLiuMNanoparticles as drug delivery systems of combination therapy for cancerNanobiomaterials in Cancer TherapySeventh EdElsevier2016253280
   Google Scholar
• NarayananSPavithranMViswanathASequentially releasing dual-drug-loaded PLGA-casein core/shell nanomedicine: design, synthesis, biocompatibility and pharmacokineticsActa Biomater20141052112212424389318
   PubMed Web of Science ®Google Scholar
• MayaSSarmentoBLakshmananVKMenonDJayakumarRActively targeted cetuximab conjugated γ-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cellsJ Biomed Nanotechnol20141081416142825016642
   PubMed Web of Science ®Google Scholar
• MayaSSarmentoBLakshmananVKMenonDSeabraVJayakumarRChitosan cross-linked docetaxel loaded EGF receptor targeted nanoparticles for lung cancer cellsInt J Biol Macromol20146953254124950310
   PubMed Web of Science ®Google Scholar
• LinYHMiFLChenCTPreparation and characterization of nanoparticles shelled with chitosan for oral insulin deliveryBiomacromolecules20078114615217206800
   PubMed Web of Science ®Google Scholar
• TangDYuSHoYMiFKuoPSungHHeparinized chitosan/poly(γ-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparinBiomaterials201031359320933220863557
   PubMed Web of Science ®Google Scholar
• LiSSchmitzKRJeffreyPDWiltziusJJWKussiePFergusonKMStructural basis for inhibition of the epidermal growth factor receptor by cetuximabCancer Cell20057430131115837620
   PubMed Web of Science ®Google Scholar
• SteffenCThomasKHuniarUHellwegARubnerOSchroerATmoleX–a graphical user interface for TURBOMOLEJ Comput Chem201031162967297020928852
   PubMed Web of Science ®Google Scholar
• TrottOOlsonAJSoftware news and update AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJ Comput Chem201031245546119499576
   PubMed Web of Science ®Google Scholar
• KikuchiOOhashiSHoribeTNovel EGFR-targeted strategy with hybrid peptide against oesophageal squamous cell carcinomaSci Rep Epub392016
   Google Scholar
• KraljSRojnikMRomihRJagodičMKosJMakovecDEffect of surface charge on the cellular uptake of fluorescent magnetic nanoparticlesJ Nanoparticle Res201214101151
   Google Scholar
• SchwartzGKTargeting the Cell Cycle: A New Approach to Cancer TherapyJ Clin Oncol200523369408942116361640
   PubMed Web of Science ®Google Scholar
• StockertJCBlázquez-CastroACañeteMHorobinRWVillanuevaÁMTT assay for cell viability: Intracellular localization of the formazan product is in lipid dropletsActa Histochem2012114878579622341561
   PubMed Web of Science ®Google Scholar
• LyJDGrubbDRLawenAThe mitochondrial membrane potential (Δψm) in apoptosis; an updateAPOPTOSIS20038211512812766472
   PubMed Web of Science ®Google Scholar
• MayaSSarmentoBLakshmananVKMenonDJayakumarRActively targeted cetuximab conjugated γ-poly(glutamic acid)-docetaxel nanomedicines for epidermal growth factor receptor over expressing colon cancer cellsJ Biomed Nanotechnol20141081416142825016642
   PubMed Web of Science ®Google Scholar
• HrkachJVon HoffDMukkaram AliMPreclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profileSci Transl Med20124128128ra39
   PubMed Web of Science ®Google Scholar
• WernerMECummingsNDSethiMPreclinical evaluation of Genexol-PM, a nanoparticle formulation of paclitaxel, as a novel radiosensitizer for the treatment of non small cell lung cancerInt J Radiat Oncol2013863463468
   PubMedGoogle Scholar
• ErnstingMJMurakamiMUndzysEAmanAPressBLiSDA docetaxel-carboxymethylcellulose nanoparticle outperforms the approved taxane nanoformulation, Abraxane, in mouse tumor models with significant control of metastasesJ Control Release2012162357558122967490
   PubMed Web of Science ®Google Scholar
• EngelsFKSparreboomAMathotRAAVerweijJPotential for improvement of docetaxel-based chemotherapy: a pharmacological reviewBr J Cancer200593217317716012521
   PubMed Web of Science ®Google Scholar
• BentonGArnaoutovaIGeorgeJKleinmanHKKoblinskiJMatrigel: from discovery and ECM mimicry to assays and models for cancer researchAdv Drug Deliv Rev20147931824997339
   PubMed Web of Science ®Google Scholar
• MullenPThe use of matrigel to facilitate the establishment of human cancer cell lines as xenograftsMethods Mol Med20048828729214634240
   PubMedGoogle Scholar
• Okochi-TakadaEHattoriNTsukamotoTANGPTL4 is a secreted tumor suppressor that inhibits angiogenesisOncogene201433172273227823686315
   PubMedGoogle Scholar
• TeicherBATumor models for efficacy determinationMol Cancer Ther20065102435244317041086
   PubMed Web of Science ®Google Scholar
• NooraniLStenzelMLiangRPourgholamiMHMorrisDLAlbumin nanoparticles increase the anticancer efficacy of albendazole in ovarian cancer xenograft modelJ Nanobiotechnology20151312525890381
   PubMedGoogle Scholar
• WangTKievitFMVeisehOTargeted cell uptake of a noninternalizing antibody through conjugation to iron oxide Nanoparticles in primary central nervous system lymphomaWorld Neurosurg2013801–213414123298674
   PubMedGoogle Scholar
• Northwestern UniversityOffice for ResearchCenter for Advanced MicroscopyZ Stack Available from: https://cam.facilities.northwestern.edu/588-2/z-stack/Accessed June 1, 2017
   Google Scholar
• Confocal tutorial: Applications: 3D reconstructionAMU Dept Pathol Univ Hel Available from: http://www.hi.helsinki.fi/amu/AMU%20Cf_tut/cf_tut_part2-3.htmAccessed June 1, 2017
   Google Scholar
• MonteroAFossellaFHortobagyiGValeroVDocetaxel for treatment of solid tumours: a systematic review of clinical dataLancet Oncol20056422923915811618
   PubMed Web of Science ®Google Scholar
• Hernández-VargasHPalaciosJMoreno-BuenoGMolecular profiling of docetaxel cytotoxicity in breast cancer cells: uncoupling of aberrant mitosis and apoptosisOncogene200726202902291317099726
   PubMed Web of Science ®Google Scholar
• PerelmanAWachtelCCohenMHauptSShapiroHTzurAJC-1: alternative excitation wavelengths facilitate mitochondrial membrane potential cytometryCell Death Dis2012311e43023171850
   PubMedGoogle Scholar
• ChuKSHasanWRawalSPlasma, tumor and tissue pharmacokinetics of Docetaxel delivered via nanoparticles of different sizes and shapes in mice bearing SKOV-3 human ovarian carcinoma xenograftNanomedicine Nanotechnology, Biol Med201395686693
   PubMed Web of Science ®Google Scholar
• LiXWangDZhangJPanWPreparation and pharmacokinetics of docetaxel based on nanostructured lipid carriersJ Pharm Pharmacol200961111485149219903373
   PubMed Web of Science ®Google Scholar
• WainbergZAAnghelADesaiAJLapatinib, a dual EGFR and HER2 kinase inhibitor, selectively inhibits HER2-amplified human gastric cancer cells and is synergistic with trastuzumab in vitro and in vivoClin Cancer Res20101651509151920179222
   PubMed Web of Science ®Google Scholar
• XuJGattaccecaFAmijiMBiodistribution and pharmacokinetics of EGFR-targeted thiolated gelatin nanoparticles following systemic administration in pancreatic tumor-bearing miceMol Pharm20131052031204423544877
   PubMedGoogle Scholar
• NascimentoAVSinghABousbaaHFerreiraDSarmentoBAmijiMMMad2 checkpoint gene silencing using epidermal growth factor receptor-targeted chitosan nanoparticles in non-small cell lung cancer modelMol Pharm201411103515352725256346
   PubMedGoogle Scholar
• NascimentoAVGattaccecaFSinghABiodistribution and pharmacokinetics of Mad2 siRNA-loaded EGFR-targeted chitosan nanoparticles in cisplatin sensitive and resistant lung cancer modelsNanomedicine201611776778126980454
   PubMed Web of Science ®Google Scholar
• NascimentoAVSinghABousbaaHFerreiraDSarmentoBAmijiMMCombinatorial designed epidermal growth factor receptor targeted chitosan nanoparticles for encapsulation and delivery of lipid-modified platinum derivatives in wild type and resistant Non small cell lung cancer cellsMol Pharm201512124466447726523837
   PubMedGoogle Scholar
• SeshacharyuluPPonnusamyMPHaridasDJainMGantiAKBatraSKTargeting the EGFR signaling pathway in cancer therapyExpert Opin Ther Targets2012161153122239438
   PubMed Web of Science ®Google Scholar
• PrewettMCHooperATBassiREllisLMWaksalHWHicklinDJEnhanced antitumor activity of anti-epidermal growth factor receptor monoclonal antibody IMC-C225 in combination with irinotecan (CPT-11) against human colorectal tumor xenograftsClin Cancer Res200285994100312006511
   PubMed Web of Science ®Google Scholar
• SaltzLBMeropolNJLoehrerPJNeedleMNKopitJMayerRJPhase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptorJ Clin Oncol20042271201120814993230
   PubMed Web of Science ®Google Scholar
• GunnJParkSIVeisehOPressOWZhangMA pretargeted nanoparticle system for tumor cell labelingMol Biosyst20117374274821107453
   PubMedGoogle Scholar
• WartlickHMichaelisKBalthasarSStrebhardtKKreuterJLangerKHighly specific HER2-mediated cellular uptake of antibody modified nanoparticles in tumour cellsJ Drug Target200412746147115621671
   PubMed Web of Science ®Google Scholar
• ThomasTPPatriAKMycAIn vitro targeting of synthesized antibody conjugated dendrimer nanoparticles †Biomacromolecules2004562269227415530041
   PubMed Web of Science ®Google Scholar
• LuoYLingYGuoWDocetaxel loaded oleic acid-coated hydroxyapatite nanoparticles enhance the docetaxel-induced apoptosis through activation of caspase-2 in androgen independent prostate cancer cellsJ Control Release2010147227828820655966
   PubMedGoogle Scholar
• PientaKJPreclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancerSemin Oncol2001284 Suppl 1537
   PubMed Web of Science ®Google Scholar
• TsakalozouEEckmanAMBaeYCombination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer CellsBiochem Res Int20122012110
   Google Scholar
• EsmaeiliFGhahremaniMHOstadSNFolate-receptor-targeted delivery of docetaxel nanoparticles prepared by PLGA-PEG-folate conjugateJ Drug Target200816541542318569286
   PubMed Web of Science ®Google Scholar
• RajuAMuthuMSFengSSTrastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxelExpert Opin Drug Deliv201310674776023458409
   PubMed Web of Science ®Google Scholar
• NarayananSMonyUVijaykumarDKKoyakuttyMPaul-PrasanthBMenonDSequential release of epigallocatechin gallate and paclitaxel from PLGA-casein core/shell nanoparticles sensitizes drug-resistant breast cancer cellsNanomedicine20151161399140625888278
   PubMed Web of Science ®Google Scholar
• LiCNewmanRAWuQ-PBiodistribution of paclitaxel and poly(l -glutamic acid)-paclitaxel conjugate in mice with ovarian OCa-1 tumorCancer Chemother Pharmacol200046541642211127947
   PubMedGoogle Scholar
• YueCLiuPZhengMIR-780 dye loaded tumor targeting theranostic nanoparticles for NIR imaging and photothermal therapyBiomaterials201334286853686123777910
   PubMed Web of Science ®Google Scholar
• ThielKWHernandezLIDassieJPDelivery of chemo-sensitizing siRNAs to HER2+-breast cancer cells using RNA aptamersNucleic Acids Res201240136319633722467215
   PubMed Web of Science ®Google Scholar
• SunXRossinRTurnerJLAn assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistributionBiomacromolecules2005652541255416153091
   PubMed Web of Science ®Google Scholar
• LiCWangCYangHZhaoXWeiNCuiJLiposomal topotecan formulation with a low polyethylene glycol grafting density: pharmacokinetics and antitumour activityJ Pharm Pharmacol201264337238222309269
   PubMedGoogle Scholar
• SteinerPJoynesCBassiRTumor growth inhibition with cetuximab and chemotherapy in non-small cell lung cancer xenografts expressing wild-type and mutated epidermal growth factor receptorClin Cancer Res20071351540155117332300
   PubMedGoogle Scholar